Second-line Therapy (TASER-P)
TASER-Pediatrics: Prospective Monitoring of Second-line Antiretroviral Therapy Failure and Resistance in Children
Sponsor: Chiang Mai University
This observational or N/A phase trial investigates Treatment Failure of Second-line ART in Asian HIV-infected Children and is currently completed. Chiang Mai University leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
12 versions recorded-
Feb 2025 — Present [monthly]
Completed
-
Sep 2024 — Feb 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2023 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Feb 2023 [monthly]
Completed
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chiang Mai University
- Children's Hospital Number 1, Ho Chi Minh City, Vietnam
- Dr Cipto Mangunkusumo General Hospital
- Kirby Institute
- Mahidol University
- Number 2 Children's Hospital, Ho Chi Minh City
- Pediatric Institute, Hospital Kuala Lumpur
- Srinagarind Hospital, Khon Kaen University
- The HIV Netherlands Australia Thailand Research Collaboration
- University of California, San Francisco
- amfAR, The Foundation for AIDS Research
For direct contact, visit the study record on ClinicalTrials.gov .